Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.589117
Title: Antibody mediated rejection and complement deposition post cardiac transplantation : a study into the relationship with coronary artery vasculopathy
Author: Moseley, E. L.
Awarding Body: University of the West of England, Bristol
Current Institution: University of the West of England, Bristol
Date of Award: 2013
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
Cardiac transplantation continues to be the main treatment pathway for end stage heart failure. The process holds many challenges for the recipients' immune system. Modern immunosuppression has improved survival to one year greatly, but the main limitation to survival following this remains chronic rejection, taking the form of coronary artery vasculopathy (CA V). Recent studies have found strong associations with antibody mediated rejection and CA V. This study investigates the role of antibody mediated rejection (AMR), and the complement system, within cardiac transplantation and it involvement with the development of CAV. Here, the presence of complement components was demonstrated within cardiac tissues taken through the transplant process and up regulated following brain death, through ischaemia and reperfusion of the graft. The deposition of complement within the first two years post transplantation was retrospectively associated with the future development of CA V. However, the deposition of complement alone did not reflect the occurrence of clinical AMR episodes. Antibodies within the tissues were also observed, with serum studies confirming the presence of auto reactive anti vimentin IgM, within the recipients. Developing the study further to investigate the CA V lesion, complement components and antibodies were co-localised to smooth muscle cells within the lesion. These data have led to the conclusion that antibody and complement deposition have a pivotal role in the cause and progression of CA V. Investigations into the source of the anti graft antibody, led to a six month post operative survey ofB cell population in cardiac recipients, leading to description of an altered B cell population within an immunosuppressed environment, with expansion in a little known CD21 10w B cell phenotype.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.589117  DOI: Not available
Share: